E Israel-Assayag
Overview
Explore the profile of E Israel-Assayag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Girard M, Israel-Assayag E, Cormier Y
Eur Respir J
. 2010 Jul;
37(3):632-9.
PMID: 20650993
Hypersensitivity pneumonitis (HP) is characterised by lung lymphocytosis. Most individuals exposed to HP antigens remain asymptomatic. The mechanisms involved in the impaired immune tolerance leading to HP are unclear. Normally,...
2.
Girard M, Israel-Assayag E, Cormier Y
Eur Respir J
. 2009 Mar;
34(3):749-56.
PMID: 19282343
The present study verified the hypothesis that enhanced maturation of antigen-presenting CD11c(+) cells could explain the viral-induced exacerbated immune response to Saccharopolyspora rectivirgula (SR), the main antigen responsible for farmer's...
3.
Blanchet M, Israel-Assayag E, Cormier Y
Eur Respir J
. 2005 Jul;
26(1):21-7.
PMID: 15994385
Nicotinic agonists, including 1,1-dimethyl-4-phenylpiperazinium (DMPP), have anti-inflammatory properties and in some instances smooth muscle relaxing effects. Since inflammation and airway smooth muscle contraction are two major components of asthma, the...
4.
Dorion G, Israel-Assayag E, Beaulieu M, Cormier Y
Am J Physiol Lung Cell Mol Physiol
. 2005 Feb;
288(6):L1139-45.
PMID: 15695540
Bronchial hyperresponsiveness is one of the main features of asthma. A nicotinic receptor agonist, 1,1-dimethylphenyl 1,4-piperazinium (DMPP), has been shown to have an inhibitory effect on airway response to methacholine...
5.
Laflamme C, Israel-Assayag E, Cormier Y
Eur Respir J
. 2003 Mar;
21(2):225-31.
PMID: 12608434
The aim of this study was to look at the apoptosis of alveolar lymphocytes in hypersensitivity pneumonitis (HP). HP patients and normal unexposed controls were studied. The percentage of apoptotic...
6.
Israel-Assayag E, Cormier Y
Eur Respir J
. 2002 May;
19(5):833-7.
PMID: 12030721
Swine confinement workers, exposed to high levels of organic dust, present a high prevalence of respiratory symptoms but show only mild lung inflammation. This contrasts with the intense inflammatory response...
7.
Cormier Y, Israel-Assayag E
Curr Opin Pulm Med
. 2000 Aug;
6(5):420-3.
PMID: 10958233
Hypersensitivity pneumonitis (HP) is a worldwide lung disease caused by an immune response to a variety of mostly organic inhaled antigens. Only a small percentage (for example, 3 in 1000...
8.
Cormier Y, Israel-Assayag E, Racine G, Duchaine C
Eur Respir J
. 2000 Apr;
15(3):560-5.
PMID: 10759453
This study investigated whether clean swine confinement buildings (SCB) are less harmful to the respiratory system than older and dirtier facilities. Eight healthy volunteers were exposed for 4 h, at...
9.
Israel-Assayag E, Fournier M, Cormier Y
J Immunol
. 1999 Dec;
163(12):6794-9.
PMID: 10586079
Hypersensitivity pneumonitis (HP) is characterized by an influx of activated T cells in the lungs. The CD28/B7 system provides costimulatory signals essential for complete T cell activation and differentiation. We...
10.
Israel-Assayag E, Dakhama A, Lavigne S, Laviolette M, Cormier Y
Am J Respir Crit Care Med
. 1999 Jun;
159(6):1830-4.
PMID: 10351927
To verify whether alveolar macrophages (AM) of patients with hypersensitivity pneumonitis (HP) increase their antigen-presenting capacity by upregulating the expression of B7 costimulatory molecules (CD80, CD86), and whether a viral...